NCT00484003View on ClinicalTrials.gov

A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2004

Study Completion Date

December 31, 2004

Conditions
Atopic Eczema
Interventions
DRUG

Pimecrolimus cream 1%

Trial Locations (1)

Unknown

Investigative Sites, Various Cities

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY